Literature DB >> 9917377

Cross-linking localization of a HIV-1 reverse transcriptase peptide involved in the binding of primer tRNALys3.

E Dufour1, J Reinbolt, M Castroviejo, B Ehresmann, S Litvak, L Tarrago-Litvak, M L Andreola.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) initiates the synthesis of DNA from the 3' end of its specific primer, tRNALys3. The regions of tRNALys3 in close contact with RT are well known, while a precise knowledge of the RT regions interacting with tRNALys3 is not yet available. To address this question we cross-linked the heterodimeric p66/p51 RT to tRNALys3 using cis-aquahydroxydiammino-platinum. Ribonucleoprotein complexes of molecular masses higher than the p66 subunit were obtained. After RNase A digestion of the RT-tRNA complex, a labeled oligoribonucleotide (ORN) was mainly found associated to the p66 subunit. This labeled p66-ORN complex was then proteolyzed with Staphylococcus aureus V8 protease. A highly purified radioactive peptide was obtained after two chromatographic purification steps. Its N-terminal sequence corresponded with amino acid residues 241VQPI244. Using the crystallographic structure of HIV-1 RT, this peptide was localized at the beta14-sheet end, near to the hairpin formed by beta12 and beta13-sheets ("primer grip") and the alphaH-helix. The so called "VQPI peptide" is in the border of the thumb and the palm subdomains of the p66 subunit. This study palliates the absence of a three- dimensional structure of the RT-tRNA complex and led to a peptide in interaction with tRNALys3 present in all HIV-1 RT isolates. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9917377     DOI: 10.1006/jmbi.1998.2430

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  11 in total

Review 1.  HIV Genome-Wide Protein Associations: a Review of 30 Years of Research.

Authors:  Guangdi Li; Erik De Clercq
Journal:  Microbiol Mol Biol Rev       Date:  2016-06-29       Impact factor: 11.056

2.  Transfer of primer binding site-mutated simian immunodeficiency virus vectors by genetically engineered artificial and hybrid tRNA-like primers.

Authors:  A C Hansen; T Grunwald; A H Lund; A Schmitz; M Duch; K Uberla; F S Pedersen
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

3.  Simon Litvak (1942-2022).

Authors:  Marcelo López-Lastra; Vincent Parissi; Jean-Luc Darlix
Journal:  Retrovirology       Date:  2022-05-19       Impact factor: 3.768

4.  Picazoplatin, an azide-containing platinum(II) derivative for target analysis by click chemistry.

Authors:  Jonathan D White; Maire F Osborn; Alan D Moghaddam; Lindsay E Guzman; Michael M Haley; Victoria J DeRose
Journal:  J Am Chem Soc       Date:  2013-08-06       Impact factor: 15.419

5.  Inability of human immunodeficiency virus type 1 produced in murine cells to selectively incorporate primer formula.

Authors:  Min Wei; Yiliang Yang; Meijuan Niu; Laurie Desfosse; Robert Kennedy; Karin Musier-Forsyth; Lawrence Kleiman
Journal:  J Virol       Date:  2008-10-08       Impact factor: 5.103

6.  Forced selection of a human immunodeficiency virus type 1 variant that uses a non-self tRNA primer for reverse transcription: involvement of viral RNA sequences and the reverse transcriptase enzyme.

Authors:  Truus E M Abbink; Nancy Beerens; Ben Berkhout
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

Review 7.  Formation of the tRNALys packaging complex in HIV-1.

Authors:  Lawrence Kleiman; Christopher P Jones; Karin Musier-Forsyth
Journal:  FEBS Lett       Date:  2010-01-21       Impact factor: 4.124

8.  Incorporation of pol into human immunodeficiency virus type 1 Gag virus-like particles occurs independently of the upstream Gag domain in Gag-pol.

Authors:  Shan Cen; Meijuan Niu; Jenan Saadatmand; Fei Guo; Yue Huang; Gary J Nabel; Lawrence Kleiman
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

9.  In vitro recombination catalyzed by bacterial class 1 integron integrase IntI1 involves cooperative binding and specific oligomeric intermediates.

Authors:  Véronique Dubois; Carole Debreyer; Claudine Quentin; Vincent Parissi
Journal:  PLoS One       Date:  2009-04-21       Impact factor: 3.240

10.  Inhibition of hepatitis C virus (HCV) RNA polymerase by DNA aptamers: mechanism of inhibition of in vitro RNA synthesis and effect on HCV-infected cells.

Authors:  Pantxika Bellecave; Christian Cazenave; Julie Rumi; Cathy Staedel; Ophélie Cosnefroy; Marie-Line Andreola; Michel Ventura; Laura Tarrago-Litvak; Thérèse Astier-Gin
Journal:  Antimicrob Agents Chemother       Date:  2008-03-17       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.